Genetic alterations affecting Cyclin D1, and control exit from the G1 phase of the cell cycle, are frequently documented in human cancers and inactivation of this pathway may as well be necessary for tumor development [25, 27]. This evidence concerns the gene CCND1 and neoplasm.